Antiviral L-nucleosides specific for hepatitis B virus infection - Wikidata - awgldk - TriplyDB

Antiviral L-nucleosides specific for hepatitis B virus infection

Antiviral L-nucleosides specific for hepatitis B virus infection

http://www.wikidata.org/entity/Q28345251

about

Telbivudine for chronic hepatitis B Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B Reaction of human UMP-CMP kinase with natural and analog substrates Clinicopathological Features of Telbivudine-Associated Myopathy Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agents.The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.L-valine ester of cyclopropavir: a new antiviral prodrug.Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review.Antiviral treatment of chronic hepatitis B virus (HBV) infections Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implications Nonclinical safety profile of telbivudine, a novel potent antiviral agent for treatment of hepatitis B Pharmacokinetics of telbivudine in subjects with various degrees of hepatic impairment.Pharmacokinetics of telbivudine in healthy subjects and absence of drug interaction with lamivudine or adefovir dipivoxil.Comparison of the antiviral effects of different nucleos(t)ide analogues in chinese patients with chronic hepatitis B: a head-to-head study.Hepatitis B virus resistance to lamivudine and its clinical implications.Combination therapy for hepatitis B Presteady state kinetic investigation of the incorporation of anti-hepatitis B nucleotide analogues catalyzed by noncanonical human DNA polymerases Enantioselectivity of human AMP, dTMP and UMP-CMP kinases.Emerging treatments in chronic hepatitis B.Review article: Nucleoside analogues for the treatment of chronic hepatitis B.Tight binding enantiomers of pre-clinical drug candidates.Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B.Telbivudine: an upcoming agent for chronic hepatitis B.Telbivudine: a novel nucleoside analog for chronic hepatitis B.Clevudine: a potent inhibitor of hepatitis B virus in vitro and in vivo.Telbivudine: a new option for the treatment of chronic hepatitis B.Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): DNA viruses.Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir Treatment of chronic hepatitis B: focus on telbivudine.Deoxyuridine analog nucleotides in deoxycytidine analog treatment: secondary active metabolites?Safety evaluation of telbivudine.Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses.Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.Molecular diagnosis and treatment of drug-resistant hepatitis B virus.Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3'-azido-2',3'-dideoxypurine nucleosides.Pharmacology of beta-L-thymidine and beta-L-2'-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virus.

P2860

Q24235644-C9C7DB25-CC1A-477C-B769-8E007E3E4C66 Q24672068-BCC29E1E-6FE6-4A6A-BB33-B4735CE4580C Q27030828-5939CB73-B10E-4D4B-BF8F-75E039FB4E71 Q28190843-E596F669-1FEE-4BB0-88FD-156B4FA4C70F Q28553983-7A867701-9830-4B10-9CB6-0E2B003AC22A Q31064047-9AE26579-3B9B-45F0-8D31-4FF4FC314D1A Q33787525-964B978A-6CEA-4175-9485-1905D28B48D3 Q33883722-76D852B4-1825-4DC7-A0B2-5E9F9AECF151 Q34096928-8EE6C344-C9CD-45EF-91D4-C7E17476F737 Q34128296-DFC18234-4A1F-4F80-9E7E-EFAC49A18B71 Q34223779-EE06BD45-7019-466E-B954-DBF89672F241 Q34299035-FC908EDA-1FF5-43F5-9B90-926522F089A5 Q34509668-6E243413-9F49-4BD2-A7CD-D8780318309F Q34591879-0D9CC33C-728E-4612-B7B8-A71D43FC679F Q34648651-26FF4C2D-A829-4CBC-9CC7-1BFBC172DC98 Q34721525-4B8DFB49-F40C-4F22-B989-750009092FEA Q34735876-BD5BED66-EB23-4DD3-9E3A-8F4AF8073FE0 Q35007583-D55D8576-C40D-4723-BCFA-BC122EF37CE2 Q35594472-F24E6B12-54AA-4C10-9C18-5F7FE32F99CC Q35675387-670D85C1-28EC-43CA-822B-6C428697EFEF Q35945458-8CEC7B10-5841-4DAC-B9DC-81020A6D0ECA Q35967369-C3A38559-1E92-40C0-B867-16C519045543 Q35987869-00ECF85E-4C68-4D9C-A66E-7ED600CE9A2A Q36052612-0743CF7A-27B9-4DD3-8391-99B172980F7A Q36094811-67A1F40F-F00D-4D26-B91D-795A01AA89E1 Q36120804-0E2E0932-564B-4F24-B2F9-2B8F06532DC9 Q36233495-4AFA5462-1373-479F-892A-45F133431460 Q36409512-9637B8CF-F6CF-4B3B-83D7-1966D0B5EF98 Q36607389-4D2D6FAE-1E93-4426-8527-90C6AA0BA8D2 Q36810314-F7B85FB2-E55C-4583-B7D3-EE6E0995A095 Q37252268-131DC963-CCBC-4AA9-8BCC-253B4274D58D Q37334120-FD7BCA08-F78B-4A5D-8AC2-6C3FB971184A Q37432074-BE1EB7C6-475B-48DB-9877-ADA8ED4E9FC7 Q37701947-32588F7B-B848-4DBA-8697-6342F0F6084E Q37775959-395987B1-5389-4B3A-9C45-D5E13C7CBE5D Q37779093-67A45DED-E4A7-4F13-A920-1E8FE4634EEB Q38071400-85FB3EA4-3765-4323-823A-6E6F234BFE84 Q38219020-26CC8A89-9EFF-4AEE-AF0E-7C6C78410B14 Q39519226-335FF065-0C4A-4609-8716-6C5DA7441DE1 Q39652022-6B8E83B7-F5D2-4AB6-98C6-BF12136D3AF8

P2860

Antiviral L-nucleosides specific for hepatitis B virus infection

http://www.wikidata.org/entity/Q28345251

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Antiviral L-nucleosides specific for hepatitis B virus infection

@ast

Antiviral L-nucleosides specific for hepatitis B virus infection

@en

Antiviral L-nucleosides specific for hepatitis B virus infection

@nl

type

label

Antiviral L-nucleosides specific for hepatitis B virus infection

@ast

Antiviral L-nucleosides specific for hepatitis B virus infection

@en

Antiviral L-nucleosides specific for hepatitis B virus infection

@nl

prefLabel

Antiviral L-nucleosides specific for hepatitis B virus infection

@ast

Antiviral L-nucleosides specific for hepatitis B virus infection

@en

Antiviral L-nucleosides specific for hepatitis B virus infection

@nl

P1433

Q28345251-5083D43C-7843-4F54-AEC5-6D71F378BE84

P1476

Q28345251-3FF37897-7A0F-4194-84C5-961FC292CAE1

P2093

Q28345251-0305FE1C-489B-4724-B154-93F54C1F0AC3

Q28345251-05F976A4-B92B-4098-AA0D-994DEDF15132

Q28345251-1662AB97-9D66-4214-A6ED-5BD4973493E8

Q28345251-1A3C3B5A-471F-40BE-B22E-03B49E94EAC6

Q28345251-44A8702D-5AF1-4210-A7F5-18B4BB946CBD

Q28345251-4A2E0A8C-FAF7-417F-9978-30C69C6A6CC6

Q28345251-573FA2E0-7929-41F2-B221-C552A21FC4CD

Q28345251-64256E86-0354-4523-8B68-6C58BA94F58F

Q28345251-71F31D74-74EB-4D11-93A3-E8C34FB41685

Q28345251-7700DA1B-FEBC-4FF6-8EEA-B7404513D5E7

P2860

Q28345251-02AC1F54-5D82-4D37-BD9F-79E285659F62

Q28345251-047074DA-D92A-48C9-A7E4-1CD46A1CA1E8

Q28345251-1AA4F11B-38DC-4DE8-84D3-1F07491CB823

Q28345251-1CEECA21-E5A7-4A93-B17C-0B57EF0F4A3D

Q28345251-1D974B2B-4488-4D76-B570-F23907F09B30

Q28345251-1F0EA05C-F02B-4147-81C5-FD0FF0170C12

Q28345251-25F17A3D-4B70-4BCC-ACE9-553A4929A34E

Q28345251-37706FFE-93D8-47BA-81AA-19C5E1FBCD67

Q28345251-410EEB65-1C96-4A34-96FF-43393A8D0489

Q28345251-49FCA9E8-A45A-48F6-88BD-E442A3F26CCA

P304

Q28345251-927F182A-7C47-4784-816F-893FE316E3E7

P31

Q28345251-3EDC73EE-21A8-4CB7-8E92-E8B7865803BB

P3181

Q28345251-397B4D82-5649-4B9F-9488-D599F91D0E26

P356

Q28345251-C5D9A96C-9184-46DC-892D-924BE4479DC5

P407

Q28345251-CD1C0A84-CF84-49DC-980C-24547B83E357

P433

Q28345251-B764D9D2-8F20-43FA-8BFF-752E09D08043

P478

Q28345251-0B8FEB94-C282-4012-83C6-9FC1D7863CEA

P577

Q28345251-CFB4CC41-9D68-405A-854B-A844C018D6BE

P5875

Q28345251-C2F742F9-F2A1-4D84-8AB6-981353346673

P698

Q28345251-E94E2C2C-F9FA-45DF-B48B-B2D989EEE338

P921

Q28345251-0B4AE470-0BD2-40D0-844D-BFACBA6337A2

P932

Q28345251-6D2639E4-A0C8-4DCD-A68A-0D9DF51517FC

P3181

P356

AAC.45.1.229-235.2001

P1433

Antimicrobial Agents and Chemotherapy

P1476

Antiviral L-nucleosides specific for hepatitis B virus infection

@en

P2093

A Faraj

http://www.w3.org/2001/XMLSchema#string

A G Loi

http://www.w3.org/2001/XMLSchema#string

A Juodawlkis

http://www.w3.org/2001/XMLSchema#string

B Hernandez

http://www.w3.org/2001/XMLSchema#string

B Korba

http://www.w3.org/2001/XMLSchema#string

B Tennant

http://www.w3.org/2001/XMLSchema#string

C Pierra

http://www.w3.org/2001/XMLSchema#string

D Dukhan

http://www.w3.org/2001/XMLSchema#string

E Cretton-Scott

http://www.w3.org/2001/XMLSchema#string

E G Bridges

http://www.w3.org/2001/XMLSchema#string

P2860

Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

Mitochondrial myopathy caused by long-term zidovudine therapy

Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infection: a phase I study

Intracellular metabolism of beta-L-2',3'-dideoxyadenosine: relevance to its limited antiviral activity

Uridine reverses the toxicity of 3'-azido-3'-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activity

Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogs

Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase

P304

229-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3600831

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/AAC.45.1.229-235.2001

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12207664

http://www.w3.org/2001/XMLSchema#string

P698

11120971

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

90266

http://www.w3.org/2001/XMLSchema#string